Hypertension

How to measure blood pressure
Speaker tbc

* home monitoring * ambulatory blood pressure * frequency of monitoring

Current management of hypertension
Speaker tbc

* first - fourth line therapy * the role of pharmacists/practice nurses in the management of hypertension * inequalities in management (race/deprivation)

Hypertensive urgency and emergency
Dr Iain MacIntyre, Consultant Nephrologist & Clinical Pharmacologist, NHS Lothian

* clinical definition * when to admit * initial management

Review of current guidance, which blood pressure target should we aim for?
Dr Jordana B Cohen, Associate Professor of Medicine & Epidemiology, Hospital of the University of Pennsylvania, USA

* review of US vs European vs UK guidelines * what targets should we aim for? * should we have different targets depending on patient co-morbidities 

Young adults: Investigation and management of young-onset hypertension
Professor Ian Wilkinson, Professor of Therapeutics, University of Cambridge

* investigation * management * follow-up

Women and during pregnancy
Speaker TBC

* pre-pregnancy counselling and management * hypertension during pregnancy * management post-pregnancy are patients followed up appropriately long-term

The frail and elderly - when to de-prescribe?
Speaker TBC

* what target should we be aiming for in the frail * can we de-prescribe safely * which drugs should we stop/avoid?
 

KEYNOTE LECTURE
Chair: Professor Andrew Elder, President, RCPE

How to assess and manage resistant hypertension
Speaker TBC

* what is resistant hypertension * how to investigate and manage * non-adherence

Common endocrine causes of hypertension
Speaker TBC

* common endocrine causes * testing, which drugs need stopped/interfere * interpreting results

Hypertension - a Sri Lankan perspective
Professor Priyanga Ranasinghe, Professor in Pharmacology, University of Colombo

* Sri Lankan epidemiology of hypertension * how to run a hypertension service in Sri Lanka * differences between UK and Sri Lankan management of hypertension
 

Ultra-long acting therapies (Zilebesiran)
Professor David Webb, Professor Emeritus in Clinical Pharmacology & Therapeutics, University of Edinburgh

* what is Zilebesiran * review current data * future

The role of new diabetic medications in managing blood pressure and cardiovascular risk
Professor Naveed Sattar, Professor of Cardiometabolic Medicine, University of Glasgow

* SGLT2, GLP1 effects on blood pressure * cardiovascular risk reduction * should these therapies be added to hypertension guidelines?

Tele-monitoring in primary care
Professor Brian McKinstry, General Practitioner and Emeritus Professor of Primary Care eHealth, University of Edinburgh

* how does it work * infrastructure required * outcome measures